Prognostic factors of Pneumocystis pneumonia in patients with systemic autoimmune diseases.
Takahiro KageyamaShunsuke FurutaKei IkedaShin-Ichiro KagamiDaisuke KashiwakumaTakao SugiyamaTakeshi UmibeNorihiko WatanabeMieko YamagataHiroshi NakajimaPublished in: PloS one (2019)
Although PCP can occur even in patients without these risk factors, our data demonstrate that the overall prognosis of PCP in such patients is good. Given that the standard prophylactic treatment against PCP has safety issues, the risk-stratified use of prophylactic treatment may be advisable.